Orion Group Common (ORN) News
NYSE: ORNIndustrialsMilitary/Government/TechnicalUSD
6.79-0.25 (-3.55%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ORN news summary
We found 15 recent headlines mentioning Orion Group Common (ORN): 0 in the past week and 13 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, ORN is down 3.55% at $6.79. The most recent story, "Orion Group: 3 Key Takeaways for Long-Term Investors", was published by Nasdaq on Nov 13, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Orion Group Common headlines
- Orion Group: 3 Key Takeaways for Long-Term InvestorsKey PointsSubmitted bids awaiting award reached $2 billion in the third quarter.NasdaqORN, BIO.B
- Orion Group Holdings Announces Conference ParticipationHOUSTON, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN; NYSE TX: ORN) (the “Company” or “Orion”), a leading specialty construction company, today announced that management…GlobeNewswire
- Orion Group Holdings, Inc. Appoints Mark A. Handley to Board of Directors, Expanding Board to seven DirectorsOrion Group Holdings, Inc. announced that its Board of Directors elected to increase the size of the Board from six directors to seven directors effective November 11, 2026, and appointed Mr. Mark…Nasdaq
- Mercury Appoints Duane Makin As New CTO(RTTNews) - Mercury NZ Ltd. (MCY.NZ), an electricity generation and energy retail company, on Wednesday announced that Duane Makin has been appointed to the newly created role of Chief Technology…NasdaqORN, HEI.A
- Orion Group Holdings Appoints Mark A. Handley to Board of DirectorsHOUSTON, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN; NYSE TX: ORN) (“Orion” or the “Company”), a leading specialty construction company, today announced the appointment…GlobeNewswire
- ORYZON Reports Third Quarter 2026 Financial Results and Provides Corporate UpdateMADRID and CAMBRIDGE, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a global leader in epigenetics,…GlobeNewswire
- ORYZON to Present Updated Positive Clinical Data for Iadademstat in Hematological Malignancies at ASH 2026MADRID and CAMBRIDGE, Mass., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a global leader in epigenetics,…GlobeNewswire
- Orion Group Holdings Announces New Contract Awards of $250 Million$115 Million Mission-Critical Project Marks Largest Concrete Award in Company History $115 Million Mission-Critical Project Marks Largest Concrete Award in Company HistoryGlobeNewswire
- Orion Group (ORN) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Orion Group Holdings, Inc. Reports Third Quarter 2026 ResultsOrion Group Holdings, Inc. reported its financial results for the third quarter ended September 30, 2026. The company achieved contract revenues of $256.2 million, representing a 14% increase from…Nasdaq
- ORYZON to participate in upcoming events in NovemberMADRID and CAMBRIDGE, Mass., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics,…GlobeNewswire
- Orion Marine Group (ORN) Q3 Earnings and Revenues Surpass EstimatesOrion Marine (ORN) delivered earnings and revenue surprises of +20.00% and +3.17%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?NasdaqORN, MTZ
- Orion Group Holdings Reports Third Quarter 2026 ResultsHOUSTON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN; NYSE TX: ORN) (the “Company” or “Orion”), a leading specialty construction company, today reported its financial…GlobeNewswire
- ORYZON further strengthens vafidemstat’s patent portfolio with new decisions to grantMADRID and CAMBRIDGE, Mass., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics, today…GlobeNewswire
- Wednesday Sector Laggards: Packaging & Containers, Construction StocksIn trading on Wednesday, packaging & containers shares were relative laggards, down on the day by about 4.3%. Helping drag down the group were shares of O-I Glass, down about 17.3% and shares of…NasdaqOI, PACK, ORN, IESC